Ernexa Therapeutics Inc. (ERNA) › Weighted Average Diluted SharesErnexa Therapeutics Inc. (ERNA) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 17.59M2021-12-31: 2.17M2022-12-31: 3.05M2023-12-31: 5.31M2024-12-31: 910.0K2025-12-31: 6.31M6.31M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-316.31M+593.1%2026-03-13From 2025-01-012024-12-31910.0K-82.9%2026-03-13From 2024-01-012023-12-315.31M+74.2%2025-03-12From 2023-01-012022-12-313.05M+40.9%2024-03-14From 2022-01-012021-12-312.17M-87.7%2023-03-20From 2021-01-012020-12-3117.59M—2022-07-01From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)